PeptideStack
5.2kquestions
20kanswers
220users

Why does freeze-concentration shift pH during freezing?

Asked 21 Mar 2024Modified 2.1 years agoViewed 15k times
12

Transit was eleven days with two scanning gaps, so the thermal history is partly inferred.

I would like the mechanism, because I want to be able to reason about the cases nobody has written about.

I have tried to reason it out from first principles and got to two contradictory conclusions.

So what is the mechanism, and how well established is it?

freeze-thaw
freeze-thaw

What repeated freezing does to a peptide in solution: ice-crystal shear at the growing front, freeze-concentration of solutes, pH shifts as buffer…

57 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
lyophilisation
lyophilisation

Freeze-drying: primary and secondary drying, collapse temperature, the role of bulking agents and cryoprotectants such as mannitol and trehalose,…

17 questions
shareeditfollowflag
SK
askeds_kalniete57k3821 Mar 2024

5 Answers

Sorted by votes
85

Thawing at room temperature rather than in warm water reduces the interfacial stress.

The mitigation is aliquoting. Divide the reconstituted solution into single-use volumes before the first freeze, and each aliquot then experiences exactly one cycle.

Degradation pathway by condition

PathwayDominant whenDetected by
DeamidationSolution, neutral to alkaline pHRP-HPLC, +1 Da on MS
OxidationLight, trace metals, peroxidesRP-HPLC, +16 Da on MS
HydrolysisSolution, extremes of pHRP-HPLC, fragment masses
AggregationAgitation, interfaces, high concentrationSEC, visual haze; often invisible on RP-HPLC
Freeze-concentration damageFreeze-thaw of buffered solutionSEC, loss of recovered content

Let a frozen vial reach room temperature before opening it. Opening a cold vial in humid air condenses water into the cake, which raises residual moisture and undoes what lyophilisation achieved.

The caveat is that aggregation is invisible in a clear solution below the threshold where it becomes visible.

Aliquot before the first freeze. That is the whole answer.

shareimprove this answerflag
PC
answeredpierce_count24k3818 May 2024
5The doubling-per-ten-degrees rule is the part I did not know and now use constantly. – Dr_Sara_Kuusela 8 months ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
58

Answering this needs to know whether the material is dry or in solution, since a dry powder is largely indifferent to a temperature cycle.

During freezing, solutes are excluded from the ice lattice and concentrate into the residual liquid. Local concentrations can rise many-fold, which promotes aggregation independently of temperature.

Thaw slowly at room temperature or in the refrigerator rather than in warm water. Rapid warming creates local thermal and concentration gradients that promote aggregation.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Thaw slowly and never refreeze an aliquot.

shareimprove this answerflag
IB
answeredines_brandt113k2577 May 2024
3Adding a vote because this deserves more of them. – Dr_Elias_Weiss 4 months ago
2Aliquoting before the first freeze is the advice I wish I had read two years ago. – yuki_morishita 3 months ago
add a comment
41

Answer first: each freeze-thaw cycle costs something through aggregation and pH shift, so the mitigation is aliquoting rather than choosing a better freezer.

Never refreeze a thawed aliquot. The whole point of aliquoting is that the aliquot is single-use, and refreezing it discards the benefit.

Stated carefully, a dry lyophilised powder is much less affected by a temperature cycle because there is no liquid phase for anything to concentrate into. Condensation on a cold vial opened warm is the real risk there.

Cryoconcentration of solutes at the ice front is a well-documented mechanism in freeze-thaw damage to proteins and peptides.

Dry powder tolerates cycles far better than solution does.

edited 12 May 2024 by h_pergande — clarified the distinction between purity and content

shareimprove this answerflag
HP
answeredh_pergande71k15826 Apr 2024
7Adding for future readers: the domestic leg after delivery is the part you control. – u100_marks 8 months ago
add a comment
27

The relevant detail is that buffer components crystallise at different rates during freezing, which shifts pH locally by a surprising amount.

Buffer salts crystallise at different points during freezing. Sodium phosphate is the classic example: the dibasic form crystallises first and the pH of the residual liquid falls by several units. That pH excursion is the real damage in many cases.

Aliquoting to eliminate repeated cycles is standard laboratory practice for exactly this reason.

Aliquoting itself is a handling step and introduces its own contamination opportunity.

Count cycles, not degrees. The cycle is the damaging event.

shareimprove this answerflag
AH
answeredanja_hellstrom13k272 Jul 2024
8I have kept vials both ways for a year and this matches what I saw. – gradient_slope 3 months ago
add a comment
-1

The honest answer is that people worry about the freezer temperature and should worry about the number of cycles.

Count cycles rather than worrying about degrees. Minus twenty and minus eighty differ far less than one cycle and five do.

Condensation onto cold lyophilised material on opening is a recognised handling error and is the basis for the equilibrate-before-opening rule.

The number of tolerable cycles is sequence- and formulation-dependent and no general number is honest.

Let a frozen vial reach room temperature before opening, or you condense water into it.

shareimprove this answerflag
C8
answeredcoldpack_8850k3715 Apr 2024

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.